The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2020

Filed:

Sep. 01, 2017
Applicant:

Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd., Shenzhen, Guangdong, CN;

Inventors:

Jingan Yang, Guangdong, CN;

Zhiguo Wang, Guangdong, CN;

Jing Cui, Guangdong, CN;

Xiaorou Liu, Guangdong, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2006.01); A61K 9/00 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61P 35/00 (2006.01); A61K 47/26 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/517 (2013.01); A61K 9/00 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2866 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61P 35/00 (2018.01);
Abstract

A pharmaceutical composition including neptinib is provided. The composition includes neptinib or a pharmaceutically acceptable salt thereof, and an excipient at a low risk of compatibleness. Furthermore, the pharmaceutical composition of the present invention may also include pharmaceutically acceptable organic acid or inorganic acid as a stabilizer. The content of impurity A maintains a non-significant increase in the long-term and accelerated stability investigation for the pharmaceutical composition.


Find Patent Forward Citations

Loading…